Literature DB >> 16091415

Sense and antisense transcripts of the apolipoprotein E gene in normal and ApoE knockout mice, their expression after spinal cord injury and corresponding human transcripts.

Alexander Seitz1, Dmitri Gourevitch, Xiang-Ming Zhang, Lise Clark, Pan Chen, Maja Kragol, Natasha Levenkova, John Rux, Stefan Samulewicz, Ellen Heber-Katz.   

Abstract

The apolipoprotein E (ApoE) gene has been linked to maladies such as hypercholesterolemia, CNS injury and disease. In this study, we present evidence that, in addition to the known transcript (ApoE S1) that translates into ApoE, there are three additional transcripts in mice. Two of these transcripts, ApoE S2 and ApoE S3, which are predicted to be transmembrane proteins, are transcribed from the sense strand. ApoE AS1 is transcribed from the antisense strand and is complementary to exon 4 of ApoE S1. The open reading frame of ApoE AS1 is conserved between human and mouse. The antisense transcript falls within the region of the human epsilon 4 allele that has been linked to the familial onset form of Alzheimer's disease. We also demonstrate the expression of ApoE S3 and ApoE AS1 in ApoE knockout mice, and ApoE S1 and ApoE S2 do not get transcribed. We had previously identified ApoE S1 as being upregulated in mice after spinal cord injury. In this study, we show that in spinal cord-injured C57BL/6 mice, both ApoE S1 and ApoE S3 transcripts are 10-fold upregulated and the antisense ApoE AS1 is 100-fold upregulated compared with normal levels. Such data suggest that these alternate transcripts are involved in the molecular pathogenesis of CNS disease and perhaps in ApoE expression in general, as we show that ApoE S2 and AS1 are also transcribed in human.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091415     DOI: 10.1093/hmg/ddi296

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  Mechanisms of antisense transcription initiation from the 3' end of the GAL10 coding sequence in vivo.

Authors:  Shivani Malik; Geetha Durairaj; Sukesh R Bhaumik
Journal:  Mol Cell Biol       Date:  2013-07-08       Impact factor: 4.272

Review 2.  Cell-specific production, secretion, and function of apolipoprotein E.

Authors:  Maaike Kockx; Mathew Traini; Leonard Kritharides
Journal:  J Mol Med (Berl)       Date:  2018-03-07       Impact factor: 4.599

3.  From Immunity and Vaccines to Mammalian Regeneration.

Authors:  Ellen Heber-Katz
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

Review 4.  Genomic landscape of developing male germ cells.

Authors:  Tin-Lap Lee; Alan Lap-Yin Pang; Owen M Rennert; Wai-Yee Chan
Journal:  Birth Defects Res C Embryo Today       Date:  2009-03

Review 5.  Natural antisense transcript: a concomitant engagement with protein-coding transcript.

Authors:  Keguo Li; Ramani Ramchandran
Journal:  Oncotarget       Date:  2010-10

Review 6.  A pathophysiological view of the long non-coding RNA world.

Authors:  Federico Di Gesualdo; Sergio Capaccioli; Matteo Lulli
Journal:  Oncotarget       Date:  2014-11-30

7.  A genome-wide investigation of expression characteristics of natural antisense transcripts in liver and muscle samples of pigs.

Authors:  Congying Chen; Rongxing Wei; Ruimin Qiao; Jun Ren; Hui Yang; Chenlong Liu; Lusheng Huang
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

8.  Potential pitfalls in the accuracy of analysis of natural sense-antisense RNA pairs by reverse transcription-PCR.

Authors:  Fadia Haddad; Anqi X Qin; Julie M Giger; Hongyan Guo; Kenneth M Baldwin
Journal:  BMC Biotechnol       Date:  2007-05-04       Impact factor: 2.563

9.  Redefining transcriptional regulation of the APOE gene and its association with Alzheimer's disease.

Authors:  Eun-Gyung Lee; Jessica Tulloch; Sunny Chen; Lesley Leong; Aleen D Saxton; Brian Kraemer; Martin Darvas; C Dirk Keene; Andrew Shutes-David; Kaitlin Todd; Steve Millard; Chang-En Yu
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.